Mavenclad

Cladribine

8.4 High risk

Mavenclad & White blood cell count decreased

8.0%

of users reported White blood cell count decreased

81.7%

also reported Severe reaction

83.2%

are women

Most common medical consequences

Severe reaction

81.7%

Hospitalization

18.3%

Have you experienced any negative side effects from this medication?

Mavenclad: general information

Most common side effects (96)

Most commonly affected ages

20 - 29 years

11.2%

30 - 39 years

23.2%

40 - 49 years

28.0%

50 - 59 years

24.8%

60 - 69 years

11.0%

70 - 79 years

1.8%

On this page